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hEditorial
Improving Adherence Among Adolescents With Type 1 Diabetesb
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mMeeting themany demands ofmanaging type 1 diabetes (T1D)
s difﬁcult, even for motivated adults. Numerous glucose checks,
onsideration of insulin dosing, diet and exercise, managing logis-
ics of care, and problem solving all require some degree of atten-
ion and energy around the clock every day of the year. For adoles-
ents, these burdens may be particularly onerous [1], coming at a
ime in social and cognitive development associated with sponta-
eity, increasing independence, and still developing executive
unction. Yet some adolescents succeed in controlling their diabe-
es.What allows these teens tomaintain good control while others
truggle, howdoes the clinician identify thesegroups, andwhat can
hey do to intervene for those who are putting their health at risk?
ypically, the answer is foundnot in lackof knowledgeof the illness
tself, but lack of support for the adolescent.
In Hilliard et al’s recent work, nearly 40% of adolescents stud-
ed met American Diabetes Association goals for glycosylated
emoglobin (HbA1c) andnumber of daily glucose checks [2]. This
dherent group tended to have intact educated families, lower lev-
lsofnegativeaffectboth ingeneralandspeciﬁcally relatedtoblood
lucose monitoring (BGM), and less conﬂict within the family about
iabetes. They also tended to be nonminority youth and use continu-
us subcutaneous insulin injection (thepump). This study contributes
o the literature by providing an empirical basis for grouping these
atients and showing consistency of results over a 2-year span.
These ﬁndings are generally in accord with previous research
nd highlight the need for investment in helping adolescents
ith diabetes develop and use support networks, typically their
amilies. Throughout the literature, the best control tends to be
ound in adolescents who have help managing the omnipresent
asks of diabetes management. There is strong evidence demon-
trating a fundamental connection between frequency of BGM,
ne of the bedrocks of any treatment regimen, and HbA1c [3].
GM can be seen as a measure of engagement and improves
hen families are more involved in a patient’s diabetes care [4].
Devices that made treatment easier (pumps) tend to improve
utcomes, but there is often some regression in glycemic control
ver time and technology should not be seen as a panacea.
evices that give the adolescent more information do not neces-
arily impact outcomes, and technology that requires too much
f the teen’s energy leads to fall off in adherence. Perhaps theSee Related Art
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Open access under CC BYest example of this is found in data from JDRF’s Continuous
lucose Monitoring Study [5], in which participants had a real-
ime sensor that informed them of their blood glucose. Despite
or perhaps because of) its promise of continuous feedback, ad-
lescent patients had signiﬁcantly lower rates of 6 days or more
week use than the adult or child groups in the cohort, illustrat-
ng that technology without support to help manage the oppor-
unities it provides is not the answer.
Mental health concerns also impact adherence outcomes. Rates
f depression are substantially higher in teens with T1D than the
eneral population; notably, affect and depression have been cor-
elated with decreased BGM and higher HbA1c [6,7]. Furthermore,
illiard’s ﬁnding that higher levels of family conﬂict around diabe-
es predicted poorer outcomes is consistent with the work of
ysocki and Anderson and Ellis [8,9]. These researchers have
hown the importance of family involvement in T1Dmanagement
nd demonstrated improvements in care treating the family con-
tellation rather than just the patient with diabetes.
However, engaging patients and families is hard work, often
equiring a substantial outlay of time, money, and energy, both by
he patient’s family and the medical system. The possibility of de-
ermining which teen patients are likely to do well and which are
ikely to struggle going forward allows for the tailoring of proactive
nterventions and outreach to at-risk groups to strengthen their
upports. Modiﬁable risk factors provide a clear opportunity for
ntervention, but even nonmodiﬁable risk factors, which serve as
arkers for greater risk, have value in helping the clinician stratify
eed and judiciously appropriate often scant resources in this area.
The basic understanding of how to treat diabeteswith insulin is
lmost 100years old, and the efﬁcacyof limitingmorbidity through
ntensive treatment is unquestioned [10]. It is well-known that the
sequelaeofT1Darebothexpensive [11] andseriouswith long-term
mpacts for bothpatient and family. Yet, althoughalmost 40%of the
ohort in Hilliard’s study maintained good glycemic control
hrough excellent adherence behaviors,60%were unable to do so
espite receiving care at a tertiary pediatric medical center. These
actsunderscore thedifﬁcultyofdealingwithachronicdiseasesuch
s diabetes on a daily basis—often the obstacles are not medical
nowledge or technical expertise in treating illness, but building a
ilieu inwhich the patient is motivated and supported to performicle p. 28.
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J. Borus / Journal of Adolescent Health 52 (2013) 2–3 3the tasks needed to treat the condition every day. Data show that
adolescents are not alone, as this struggle is found throughout the
life course,withamajorityofadultsnotmeetingAmericanDiabetes
Association targets for HbA1c, blood pressure, or lipid control [12].
urther study, such as replication of Hilliard’s work as part of a
ulticenter effort, is warranted to learnmore about the character-
stics that predict patient trajectories and thenwhat interventions,
uch as promoting improved family involvement, can be under-
aken to shape them by improving adherence to treatment. Advo-
acy for these services is needed, as they are often seen as too
xpensive despite compelling cost-effectiveness data in a challeng-
ng ﬁnancial environment [9]. Effective treatments that can bring
bout improved adherence have great promise to reduce experi-
nced burden of disease and bend the cost curve of medical care
13]. This highlights the need for continued discussion and atten-
ion to making it easier for adolescents with diabetes to treat their
llness by expanding opportunities to build good family supports.
Joshua Borus, M.D., M.P.H.
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